Atara Biotherapeutics (ATRA) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest ...

Investors might want to bet on Olo Inc. (OLO), as it has been recently upgraded to a Zacks Rank #2 (Buy). This upgrade primarily reflects an upward trend in earnings estimates, which is one of the ...

Here are three stocks with buy ranks and strong growth characteristics for investors to consider today, October 15th: BRF S.A ...

Unity Bancorp (UNTY) appears an attractive pick, as it has been recently upgraded to a Zacks Rank #2 (Buy). This upgrade primarily reflects an upward trend in earnings estimates, which is one of the ...

Enphase Energy (ENPH) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

A 49-year-old man was arrested at a security checkpoint near Trump's Coachella rally on Saturday. 'The world is on fire, and I’m not that interested in laundry-folding content,' the 'Succession ...

Inside the dangerous world of Russian front-line soldiers working as double agents for the enemy ...